EUVIMEDEUVIMED entdecken
Crossref

Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors

Amna Alneaemy, Abdulameer Al‑rikabi, Alaa Alwan

World Academy of Sciences Journal · 24.06.2026 · 8 (4) · 1-11

DOI: 10.3892/wasj.2026.487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Academy of Sciences Journal, online erschienen am 24.06.2026. Verfasst von Amna Alneaemy und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alneaemy, A., Al‑rikabi, A., & Alwan, A. (2026). Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors. World Academy of Sciences Journal, 8(4), 1-11. https://doi.org/10.3892/wasj.2026.487

Vancouver

Alneaemy A, Al‑rikabi A, Alwan A. Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors. World Academy of Sciences Journal. 2026;8(4):1-11. doi:10.3892/wasj.2026.487

BibTeX
@article{Alneaemy2026,
  author = {Alneaemy, Amna and Al‑rikabi, Abdulameer and Alwan, Alaa},
  title = {Molecular profiling of DNMT3A and ASXL1 in chronic myeloid leukemia and their association with response to treatment with tyrosine kinase inhibitors},
  journal = {World Academy of Sciences Journal},
  year = {2026},
  volume = {8},
  number = {4},
  pages = {1--11},
  doi = {10.3892/wasj.2026.487}
}
Kostenlos starten →